0001179110-20-001427.txt : 20200211
0001179110-20-001427.hdr.sgml : 20200211
20200211092629
ACCESSION NUMBER: 0001179110-20-001427
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200207
FILED AS OF DATE: 20200211
DATE AS OF CHANGE: 20200211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Enyedy Mark J
CENTRAL INDEX KEY: 0001586965
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17999
FILM NUMBER: 20594386
MAIL ADDRESS:
STREET 1: C/O FATE THERAPEUTICS, INC.
STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ImmunoGen, Inc.
CENTRAL INDEX KEY: 0000855654
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042726691
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781)895-0600
MAIL ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOGEN INC
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
FORM 4 -
X0306
4
2020-02-07
0
0000855654
ImmunoGen, Inc.
IMGN
0001586965
Enyedy Mark J
24 CONCORD SQUARE
BOSTON
MA
02118
1
1
0
0
Chief Executive Officer
Stock Option (right to buy)
4.55
2020-02-07
4
A
0
1050000
4.55
A
2021-02-07
2030-02-07
Common Stock
1050000
1050000
D
25% of the options are exercisable on the first year anniversary of the grant and the balance is exercisable in twelve equal installments of 6.25%, quarterly over the following three years starting one quarter after the first year anniversary.
/s/ Craig Barrows, attorney in fact
2020-02-11